Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission-Reference-Cited by-同舟云学术

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission

Published:2021-05-04 Issue:17 Volume:325 Page:1755
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Lillegraven Siri¹,Paulshus Sundlisæter Nina¹,Aga Anna-Birgitte¹,Sexton Joseph¹,Olsen Inge C.²,Fremstad Hallvard³,Spada Cristina⁴,Madland Tor Magne⁵,Høili Christian A.⁶,Bakland Gunnstein⁷,Lexberg Åse⁸,Hansen Inger Johanne Widding⁹,Hansen Inger Myrnes¹⁰,Haukeland Hilde¹¹,Ljoså Maud-Kristine Aga³,Moholt Ellen¹,Uhlig Till¹¹²,Solomon Daniel H.¹³,van der Heijde Désirée¹¹⁴,Kvien Tore K.¹¹²,Haavardsholm Espen A.¹¹²

Affiliation:

1. Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway

2. Clinical Trial Unit, Oslo University Hospital, Oslo, Norway

3. Department of Rheumatology, Ålesund Hospital, Helse Møre og Romsdal HF, Ålesund, Norway

4. Revmatismesykehuset AS, Lillehammer, Norway

5. Department of Rheumatology, Haukeland University Hospital, Bergen, Norway

6. Department of Rheumatology, Hospital Østfold HF, Moss, Norway

7. Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway

8. Department of Rheumatology, Drammen Hospital, Vestre Viken HF, Drammen, Norway

9. Department of Rheumatology, Sørlandet Hospital HF, Kristiansand, Norway

10. Department of Rheumatology, Helgelandssykehuset Mo i Rana, Mo i Rana, Norway

11. Department of Rheumatology, Martina Hansens Hospital, Bærum, Norway

12. Faculty of Medicine, University of Oslo, Oslo, Norway

13. Division of Rheumatology, Brigham and Women’s Hospital, Boston, Massachusetts

14. Department of Rheumatology, Leiden University Medical Centre, Leiden, the Netherlands

Publisher

American Medical Association (AMA)

Subject

General Medicine

Link

https://jamanetwork.com/journals/jama/articlepdf/2779548/jama_lillegraven_2021_oi_210033_1620137997.89481.pdf

Reference36 articles.

1. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.;Haavardsholm;BMJ,2016

2. Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.;Combe;J Rheumatol,2013

3. Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.;Aga;Ann Rheum Dis,2015

4. Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis.;ten Wolde;Lancet,1996

5. Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial.;Kuijper;Ann Rheum Dis,2016

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Agreement between patient-reported flares and clinically significant flare status in patients with rheumatoid arthritis in sustained remission: data from the ARCTIC REWIND trials;RMD Open;2024-09

2. Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial;The Lancet Rheumatology;2024-05

3. In situ polymeric nanomicelle-generating dissolving microneedle patch for enhanced transdermal methotrexate delivery in rheumatoid arthritis treatment;European Polymer Journal;2024-04

4. Therapeutic advances in rheumatoid arthritis;BMJ;2024-01-17

5. Performance of the Rheumatoid Arthritis Impact of Disease (RAID) score in relation to flares in disease activity;RMD Open;2024-01